City

Chicago (1)

Pittsburgh (1)

Saint Louis (1)

Seattle (1)

Condition

Head Cancer (1)

Head Cancer Neck (1)

Head and Neck Cancer (1)

Head and Neck Squamous Cell Carcinoma (1)

Neck Cancer (1)

Neck Carcinoma (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Ikena Oncology (1)

Collaborator

Bristol-Myers Squibb (1)

Intervention

ik-175 + nivolumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

neck carcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head Cancer Trial in United States (IK-175 + nivolumab)

Not yet recruiting

Head and Neck Squamous Cell Carcinoma
+5 more

IK-175 + nivolumab

Chicago, Illinois
+3 more

Jul 26, 2022